Literature DB >> 32492706

Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL.

Neeraj Saini1, David Marin1, Celina Ledesma1, Ruby Delgado1, Gabriela Rondon1, Uday R Popat1, Qaiser Bashir1, Chitra M Hosing1, Yago Nieto1, Amin M Alousi1, Muzaffar H Qazilbash1, Stefan Ciurea1, Elizabeth Shpall1, Issa Khouri1, Hagop Kantarjian2, Elias Jabbour2, Farhad Ravandi2, Richard E Champlin1, Partow Kebriaei1.   

Abstract

Entities:  

Year:  2020        PMID： 32492706     DOI： 10.1182/blood.2019004685

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward.

Authors:  Pouya Safarzadeh Kozani; Pooria Safarzadeh Kozani; Fatemeh Rahbarizadeh
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

Review 2.  Modern Management Options for Ph+ ALL.

Authors:  Josep-Maria Ribera; Sabina Chiaretti
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575

3.  Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation-A single institution experience.

Authors:  Radhika Takiar; Charles E Foucar; Anthony J Perissinotti; Bernard L Marini; Lydia Benitez-Colon; Patrick W Burke; Dale L Bixby
Journal:  Leuk Res Rep       Date:  2022-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.